CRGX CARGO Therapeutics Inc
Price (delayed)
$4.51
Market cap
$207.7M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.72
Enterprise value
$172.18M
We are a clinical-stage biotechnology company uniquely positioned to advance next generation, potentially curative cell therapies for cancer patients. Our programs, platform technologies, and manufacturing strategy are designed to directly
Highlights
The EPS has plunged by 105% from the previous quarter but it has soared by 77% YoY
The net income has dropped by 71% year-on-year and by 9% since the previous quarter
The company's quick ratio fell by 29% YoY and by 27% QoQ
Key stats
What are the main financial stats of CRGX
Market
Valuations
Earnings
Shares outstanding
46.05M
Market cap
$207.7M
Enterprise value
$172.18M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.58
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$187.37M
Net income
-$167.5M
EBIT
-$167.5M
EBITDA
-$160.43M
Free cash flow
-$143.97M
Per share
Balance sheet
Liquidity
EPS
-$3.72
EPS diluted
-$3.72
Free cash flow per share
-$3.2
Book value per share
$7.83
Revenue per share
$0
TBVPS
$9.21
Total assets
$414.05M
Total liabilities
$53.83M
Debt
$29.43M
Equity
$360.23M
Working capital
$319.99M
Debt to equity
0.08
Current ratio
13.79
Quick ratio
13.6
Net debt/EBITDA
0.22
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-37.7%
Return on equity
-42.7%
Return on invested capital
-47.1%
Return on capital employed
-43.1%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
CRGX stock price
How has the CARGO Therapeutics stock price performed over time
Intraday
-0.33%
1 week
-2.8%
1 month
7.89%
1 year
-75.33%
YTD
-68.72%
QTD
10.81%
Financial performance
How have CARGO Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$187.37M
Net income
-$167.5M
Gross margin
N/A
Net margin
N/A
The operating income has plunged by 94% YoY and by 9% from the previous quarter
The net income has dropped by 71% year-on-year and by 9% since the previous quarter
Growth
What is CARGO Therapeutics's growth rate over time
Valuation
What is CARGO Therapeutics stock price valuation
P/E
N/A
P/B
0.58
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has plunged by 105% from the previous quarter but it has soared by 77% YoY
CRGX's P/B is 69% below its last 4 quarters average of 1.9
CARGO Therapeutics's equity has decreased by 11% YoY and by 10% from the previous quarter
Efficiency
How efficient is CARGO Therapeutics business performance
CRGX's return on invested capital has surged by 90% year-on-year and by 14% since the previous quarter
CARGO Therapeutics's ROE has increased by 19% YoY but it has decreased by 12% from the previous quarter
CARGO Therapeutics's ROA has decreased by 11% from the previous quarter but it has increased by 11% YoY
Dividends
What is CRGX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for CRGX.
Financial health
How did CARGO Therapeutics financials performed over time
CRGX's current ratio is down by 29% year-on-year and by 27% since the previous quarter
The company's quick ratio fell by 29% YoY and by 27% QoQ
The debt is 92% smaller than the equity
The debt to equity has increased by 14% since the previous quarter and by 14% year-on-year
CARGO Therapeutics's equity has decreased by 11% YoY and by 10% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.